FindTrial
Sign In

Prognostic markers and molecular mechanisms in benign paroxysmal positional vertigo

Prognostic markers and molecular mechanisms in benign paroxysmal positional vertigo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019392
Enrollment
Unknown
Registered
2018-11-08
Start date
2018-12-15
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign paroxysmal positional vertigo

Interventions

BPPV group:none
control:none

Sponsors

Shanghai Sixth People's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with BPPV: 1. Recurrent, transient vertigo or dizziness (usually lasting no more than 1 minute) occurs after head position changes relative to gravity direction; 2. there was vertigo and characteristic positional nystagmus in the position test.

Exclusion criteria

Exclusion criteria: 1. patients with serious internal and external diseases such as cardiovascular and cerebrovascular diseases or organ failure; 2. lactating women or pregnant women; 3. researchers believe that patients who are not suitable for this clinical trial.

Design outcomes

Primary

MeasureTime frame
All outcomes results;—

Countries

China

Contacts

Public ContactFeng Yanmei

Shanghai Sixth People's hospital

feng.yanmei@126.com+86 021-24058706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026